Anthem Biosciences IPO on Day 2 with moderate success, price band ₹540-570, 35% reserved for retail investors.

HCL Technologies reports 9.7% decline in Q1 net profit, revenue grows 8.1%; Tata Technologies sees 10% drop in profit.

GAIL signs long-term LNG agreement, Sun Pharma settles litigation, LIC appoints new CEO, Tata Group's green steel project ...